The global Automated Nucleic Acid Extraction Market is estimated at USD 4.31 Billion in 2025 and is expected to reach USD 11.21 Billion by 2035 and grow at a CAGR of 10.03% over the forecast period of 2026–2035. As per the SNS Insider report titled, “Automated Nucleic Acid Extraction Market Size, Share & Segmentation Analysis, by Product Type, Extraction Technology, Sample Type, Application, End-User, & Region | Global Forecast 2026–2035”

There is continued rapid growth in the global market for automation in nucleic acid extraction due to the rising need for fast molecular diagnostics and genomics research. This is happening due to advancements in technology that enable more efficient processing of samples.

Rising Demand for High-Throughput Molecular Testing and Genomics Research Accelerates Market Growth Globally

One of the primary reasons supporting the expansion of the market for automated nucleic acid extraction is the increasing demand for rapid and efficient molecular testing and genomics. The growing prevalence of infectious diseases, the ability of precision medicines, and the need for diagnostic techniques are stimulating significant adoption of automated equipment across a number of industries.

Nonetheless, some impediments, such as high cost of the equipment, complication and stringent regulations still continue in this aspect.

Key Report Highlights:

  • By product type, instruments dominated with a 42.78% share in 2025, while software & data analysis tools are expected to grow fastest at a CAGR of 12.47%.
  • By extraction technology, magnetic bead-based extraction led with a 48.15% share in 2025, whereas PCR-based extraction is projected to grow at the highest CAGR of 13.05%.
  • By sample type, blood held a 37.64% share in 2025, while swabs (buccal/nasal) are the fastest-growing segment with a CAGR of 12.89%.
  • By application, clinical diagnostics accounted for a 40.52% share in 2025, while personalized medicine is expected to grow at the fastest CAGR of 13.21%.
  • By end user, hospitals & diagnostic laboratories dominated with a 45.36% share in 2025, while biotechnology & pharmaceutical companies are projected to grow at a CAGR of 12.88%.
  • Regionally, North America dominated with a 41.87% market share in 2025, while Asia-Pacific is projected to be the fastest-growing region at a CAGR of 12.51%.

Regional Outlook:

North America was the leading regional market for Automated Nucleic Acid Extraction Market, at 41.87% market share, in 2025, owing to well-developed health care infrastructure, wide acceptance of molecular diagnostics, and significant investments in genomics research. Apart from this, the existence of key players in the biotechnology sector, favorable regulations & policies, and continuing innovations in laboratory automation technologies will further empower its leading position in the market.

  • The U.S. remains the market leader in North America, driven by growing focus on personalized medicines, high adoption of laboratory automation technologies, and high investment for R&D. Laboratory efficiencies will be significantly enhanced through the adoption of automated laboratory technologies and artificial intelligence (AI).

The Asia Pacific region is predicted to be the fastest growing regional market, with a CAGR of 12.51% throughout the forecast period 2026 to 2035. This growth is primarily driven by rising healthcare expenditure, doubling of biotechnology industries, and emerging molecular diagnostics using countries, such as China, India, Japan, and South Korea.

Recent Industry Developments:

  • Thermo Fisher Scientific released in August 2025 the Applied Biosystems™ MagMAX™ HMW DNA Kit to support the quick and efficient isolation of high molecular weight DNA for genomics research.
  • The launch by QIAGEN in November 2025 was QIAsymphony Connect, an advanced nucleic acid purification system featuring improved sample tracking as well as cloud connectivity.

Leading Companies in the Automated Nucleic Acid Extraction Market:

  • Thermo Fisher Scientific
  • QIAGEN
  • Roche Diagnostics
  • Merck KGaA
  • Agilent Technologies
  • Promega Corporation
  • Bio-Rad Laboratories
  • Takara Bio
  • Zymo Research Corporation
  • PerkinElmer
  • Tecan Group
  • Hamilton Company
  • Analytik Jena AG
  • Beckman Coulter
  • Bioneer Corporation
  • LGC Biosearch Technologies
  • Illumina
  • Revvity, Inc.
  • bioMérieux
  • AutoGen, Inc.